Instrumentation Laboratory Company-医療機器分野:企業M&A・提携分析

◆英語タイトル:Instrumentation Laboratory Company - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010945
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Instrumentation Laboratory Company (IL), a subsidiary of Werfen Life Group, is a medical device company with focus on in vitro diagnostics (IVD) devices. The company develops, manufactures, and distributes IVD instruments, related reagents and controls for hospitals and clinical laboratories. Its major products include critical care systems including whole blood analyzers, CO-Oximeter and whole-blood coagulation system; hemostasis systems including testing systems, reagents, controls and calibrators; and information management systems. IL also offers various quality control products; and services such as advanced automation, quality management, clinical support and product support. The company offers its products to hospitals and independent clinical laboratories the world over. IL is headquartered in Bedford, Massachusetts, the US.

Instrumentation Laboratory Company – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Instrumentation Laboratory Company, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Instrumentation Laboratory Company, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Instrumentation Laboratory Company, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Instrumentation Laboratory Company, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Instrumentation Laboratory Company, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Instrumentation Laboratory Company, Medical Equipment, Deal Details 10
Partnerships 10
BioPorto Enters Into Licensing Agreement With Instrumentation Lab 10
Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 11
Acquisition 12
Instrumentation Labs Acquires CA Casyso 12
Instrumentation Laboratory Company – Key Competitors 13
Instrumentation Laboratory Company – Key Employees 14
Instrumentation Laboratory Company – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Financial Announcements 16
Mar 14, 2016: Instrumentation Laboratory Reports Record Worldwide Sales In 2015 16
Product News 17
Sep 26, 2016: Instrumentation Laboratory Launches HemoHub Intelligent Data Manager Worldwide 17
Aug 15, 2016: Instrumentation Laboratory Launches HemosIL ReadiPlasTin Assay Worldwide 18
Aug 11, 2016: Instrumentation Laboratory Presents New Innovations In Hemostasis At AACC Annual Meeting 19
Other Significant Developments 21
Apr 04, 2017: Instrumentation Laboratory Achieves Record Worldwide Sales In 2016 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Instrumentation Laboratory Company, Medical Equipment, Key Facts, 2015 2
Instrumentation Laboratory Company, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Instrumentation Laboratory Company, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Instrumentation Laboratory Company, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Instrumentation Laboratory Company, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Instrumentation Laboratory Company, Deals By Market, 2011 to YTD 2017 8
Instrumentation Laboratory Company, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
BioPorto Enters Into Licensing Agreement With Instrumentation Lab 10
Instrumentation Laboratory Company Enters into Partnership with Thermo Fisher Scientific 11
Instrumentation Labs Acquires CA Casyso 12
Instrumentation Laboratory Company, Key Competitors 13
Instrumentation Laboratory Company, Key Employees 14
Instrumentation Laboratory Company, Other Locations 15
Instrumentation Laboratory Company, Subsidiaries 15

★海外企業調査レポート[Instrumentation Laboratory Company-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vector Group Ltd (VGR):企業の財務・戦略的SWOT分析
    Vector Group Ltd (VGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Mitchells & Butlers plc:企業のM&A・事業提携・投資動向
    Mitchells & Butlers plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitchells & Butlers plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Hanmi Pharmaceuticals Co Ltd (128940):企業の財務・戦略的SWOT分析
    Hanmi Pharmaceuticals Co Ltd (128940) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Aptevo Therapeutics Inc (APVO):製薬・医療:M&Aディール及び事業提携情報
    Summary Aptevo Therapeutics Inc (Aptevo), a subsidiary of Emergent Biosolutions Inc, is a biotechnology company that develops and commercializes oncology and hematology therapeutics. The company’s only marketed product Ixinity that is indicated to replace the missing clotting factor IX in adults and …
  • CESC Ltd (CESC):企業の財務・戦略的SWOT分析
    CESC Ltd (CESC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Phagelux Inc-製薬・医療分野:企業M&A・提携分析
    Summary Phagelux Inc (Phagelux) is an anti-infectives company that provides antibacterial products and solutions. The company uses phage lysis enzymes and biological agents for the treatment of antibiotic resistant bacteria and related diseases in human beings and crops. Its product portfolio includ …
  • Corium International Inc (CORI):医療機器:M&Aディール及び事業提携情報
    Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products i …
  • BMO Capital and Income Investment Trust PLC:企業の戦略・SWOT・財務情報
    BMO Capital and Income Investment Trust PLC - Strategy, SWOT and Corporate Finance Report Summary BMO Capital and Income Investment Trust PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Nippon Sheet Glass Company Limited :企業の戦略・SWOT・財務情報
    Nippon Sheet Glass Company Limited - Strategy, SWOT and Corporate Finance Report Summary Nippon Sheet Glass Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Strategic Oil & Gas Ltd (SOG):企業の財務・戦略的SWOT分析
    Summary Strategic Oil & Gas Ltd (Strategic Oil & Gas) is an upstream oil and gas exploration and development company. The company acquires, explores, operates, manages, and develops crude oil and natural gas assets. It holds interests and operates its oil and gas exploration projects such as Marlowe …
  • Ingka Holding B.V.:企業の戦略・SWOT・財務情報
    Ingka Holding B.V. - Strategy, SWOT and Corporate Finance Report Summary Ingka Holding B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cascadian Therapeutics Inc (CASC):製薬・医療:M&Aディール及び事業提携情報
    Summary Cascadian Therapeutics Inc (Cascadian), formerly Oncothyreon Inc is a clinical-stage biotechnology company that develops therapeutic products for the treatment of cancer. The company’s lead clinical-stage product candidate includes ONT-380, an orally active and selective small-molecule HER2 …
  • CaixaBank SA:企業の戦略・SWOT・財務情報
    CaixaBank SA - Strategy, SWOT and Corporate Finance Report Summary CaixaBank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Penn National Gaming Inc:企業のM&A・事業提携・投資動向
    Penn National Gaming Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Penn National Gaming Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Pantheon Resources plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Pantheon Resources plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Pantheon Resources plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive informat …
  • Hyundai Rotem Co
    Hyundai Rotem Co - Strategy, SWOT and Corporate Finance Report Summary Hyundai Rotem Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Patel Engineering Ltd
    Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Capitol Health Ltd (CAJ):医療機器:M&Aディール及び事業提携情報
    Summary Capitol Health Ltd (Capitol Health) is a diagnostic imaging service provider to the healthcare market.. The company offers services such as bone densitomety, computer tomography, cone beam CT, CT angiography, doppler, echocardiography, fluoroscopy, general X-ray, magnetic resonance imaging, …
  • Nippon Steel & Sumikin Chemical Co Ltd:企業の戦略的SWOT分析
    Nippon Steel & Sumikin Chemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Gazprom Neft (SIBN):企業の財務・戦略的SWOT分析
    Gazprom Neft (SIBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆